none

UBER CO-FOUNDER INVESTS IN PHARMECUTICAL DISRUPTION

01-09-2016
by 
in 

 Oscar Salazar, co-founder of Uber, and Walter Jin, founder of Carlyle Healthcare Group, have invested in Series-A funding round and joined the board of RxAdvance, a full service Pharmacy Benefits Management company.

Oscar Salazar is a co-founder of Pager, an innovative on-demand healthcare service that utilizes a mobile patient engagement platform to connect patients with the right type of care. Prior to Pager, Oscar was a founding partner and Chief Technology Officer of Uber.

“Our goal is to leverage disruptive technology and world-class design to reinvent healthcare and deliver cost savings and efficiencies," said Oscar and Walter.

“We are proud to join the RxAdvance board, as its accountable drug benefit management practice and risk-sharing business models are timely in this antiquated industry and are perfectly aligned with the healthcare investments in which we are involved.”

“In the recent years, several successful Silicon Valley entrepreneurs and blue chip companies have entered the healthcare vertical to disrupt and transform, in vain.

This lack of success can be attributed to the absence of substantial business and revenue models, disruptive service offerings, and a proven track record in the complex healthcare eco-system,” says John Sculley, former Apple CEO and Vice Chairman of RxAdvance."

“What impressed me about Ravi and his team at RxAdvance is that they have all the essential components for success - a widely proven and successful revenue model, a solid platform and innovative thinking, a proven track record, and deep healthcare domain expertise capable of disrupting traditional paradigms throughout the care continuum. Through its innovative Collaborative PBM Cloud™, RxAdvance is challenging large incumbent PBMs by disrupting their decades-old business and revenue models, and their risk-sharing models are unheard of in the PBM market.”

There is great synergy between RxAdvance and Pager. Both brands use world class technology and clinical resources to disrupt traditional healthcare delivery practices. Through their partnership, high quality healthcare services will be made more efficient, cost-effective, and convenient.

“We are honored to have two of the leading minds in disruptive technology and business as our investment partners and board members. We at RxAdvance feel that their high-tech experience and guidance will help to transform the $770 billion PBM and associated avoidable drug-impacted medical spend that is long overdue for innovation,” says Ravi Ika, President & CEO of RxAdvance.

Related news & editorials

  1. LEAA Sector Benchmark Research
    15.04.2021
    15.04.2021
    by      In
    There is a move towards new and productive, even more technologically savvy, ways of working, according to the latest investigations by the Lifting Equipment Engineers Association (LEEA), from their sector benchmark research.
    Seventy-two percent of firms reported being optimistic for the next six... Read More
  2. 15.04.2021
    15.04.2021
    by      In
    Farmers already battered by drought, fires and floods now face large losses in crops and damaged equipment from the mice plague currently affecting areas from Queensland to Victoria to the South Australian Mallee.
    Haulage truck drivers have described ‘waves of movement’ across the road in grain... Read More
  3. australian made logo
    15.04.2021
    15.04.2021
    by      In
    You’ve seen the green and gold kangaroo on all kinds of products, but have you ever wondered exactly what it means, how it came to be, who is using it, or how you can use it yourself?
    The AMAG (Australian Made/Australian Grown) logo has been around for 35 years. Back in 1986, the Australian... Read More
  4. Hayley Glasgow
    12.04.2021
    12.04.2021
    by      In
    More than half (55%) of Australian manufacturers with off-shored operations intend to bring them back to our shores by 2023, according to a survey of 500 senior manufacturing employees in December last year.
    This is largely being driven by market volatility caused by the pandemic and strained... Read More
Products
Suppliers